reviewNature Reviews Clinical OncologyMar 31, 2016Closed access

Treating cancer with selective CDK4/6 inhibitors

BOBen O’Leary RSRichard S. Finn NCNicholas C. Turner

Institute of Cancer Research · Breast Cancer Now · +3 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,154

total citations

FWCI: 83.80
Percentile: 100%
References: 213

Citations per year

Authors

3

BO
Ben O’LearyCorresponding
Institute of Cancer Research, Breast Cancer Now
RS
Richard S. Finn
University of California, Los Angeles
NC
Nicholas C. Turner
Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Breast Cancer Now, Institute of Cancer Research

Topics & keywords

Topics

Keywords

Palbociclib
Cyclin-dependent kinase
Medicine
Cancer
Kinase
Clinical trial
Cancer research
Breast cancer

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.

Funding